| 1 |
34906743 | Tolerability of the first infusion of once-yearly zoledronic acid within one to two weeks after hip fracture surgery. | 2022 Feb |
1 |
| 2 |
32897516 | Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study. | 2021 Jan |
1 |
| 3 |
32603908 | Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption. | 2020 Sep |
1 |
| 4 |
21047568 | Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. | 2011 Jul |
1 |
| 5 |
21116816 | Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid. | 2011 Aug |
1 |